Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Thats the kind of discipline that turns a concept into a canned product worthy of serious consideration rather than a novelty
Miao suggested that physicians identify who is having a difficult time stopping tobacco use and get them connected with the appropriate resources and medical therapies available for smoking cessation efforts
Toombak dipping and cancer of the oral cavity in the Sudan: a case control study
Explore the variety of tobaccos available and start creating your custom blends today!
Selecting the right insurance company means choosing the insurer that most favorably views your tobacco status and/or offers the best rates
The following formula illustrates how CMS would calculate the inflation-adjusted payment amount for a Part D rebatable drug as proposed in 428.202(f): (Benchmark period manufacturer price) multiplied by (applicable period CPI-U divided by benchmark period CPI-U) As described earlier in this proposed rule and proposed in 428.202(a), CMS will use the inflation-adjusted payment amount to calculate the per unit Part D drug inflation rebate amount by determining the amount by which the AnMP for a Part D rebatable drug exceeds the inflation-adjusted payment amount for a Part D rebatable drug for an applicable period
US$ 22.10
US$ 24.99
US$ 22.31
US$ 28.39
US$ 25.03
